Robotic Process Automation in Healthcare Market Summary

• The global RPA in healthcare market was valued at USD 2,745.12 million in 2025 and is projected to reach USD 14,562.17 million by 2034.
• The market is expected to expand at a CAGR of 20.37% during the forecast period 2026-2034, supported by the rising need for operational efficiency, healthcare labor shortages, the increasing digitization of healthcare services, and demand for cost reduction in administrative tasks.
• By type, the software segment dominated the RPA in healthcare market with a 74% share in 2025.
• By application, the claims management segment dominated the RPA in healthcare market with a 33% share in 2025.
• By end-user, the healthcare providers segment dominated the RPA in healthcare market with a 55% share in 2025.
• North America accounted for the largest share of the RPA in healthcare market at 40% in 2025, while Asia-Pacific is anticipated to register the fastest growth through 2034.

Robotic Process Automation (RPA) in healthcare is the use of software robots, or bots, to automate the routine, repetitive, and rule-based tasks that fill healthcare administrative and operational workflows, such as data entry, billing, scheduling, and claims processing. These bots mimic human actions on digital systems, aiming to enhance efficiency, minimize manual errors, and enable healthcare workers to devote more attention to patient care. The market is organized by the type of offering supplied, the application automated, and the organization that adopts it. By type, it is divided between the software licenses that provide the automation platform and the services, including implementation, support and maintenance, and training and consulting, that surround them. By application, it spans the front-office, mid-office, and back-office processes of healthcare, including patient scheduling and registration, claims management, billing and revenue cycle management, electronic health record management and coding, and regulatory and compliance documentation. By end-user, it spans the healthcare providers that deliver care, the healthcare payers that administer insurance, and the pharmaceutical and life sciences companies that manage regulatory, pharmacovigilance, and clinical trial workflows. The market has accelerated since the COVID-19 pandemic, and it is increasingly defined by the convergence of RPA with artificial intelligence, machine learning, and natural language processing into intelligent automation and hyperautomation, in which bots handle unstructured data and cognitive tasks, and by the shift toward cloud-based and low-code platforms.

RPA in Healthcare Market Key Growth Drivers

• The rising need for administrative efficiency and cost reduction, since hospitals and clinics are burdened with time-consuming data entry, claims processing, and billing that RPA reduces while improving accuracy.
• Healthcare labor shortages and burnout, with the World Health Organization projecting a shortfall of some 11 million health workers by 2030, driving demand for digital assistants to handle repetitive processes.
• The increasing digitization of healthcare services and the integration of RPA with electronic health record and health IT platforms such as Epic and Cerner to auto-update records, manage scheduling, and synchronize data.
• The demand for compliance and audit readiness, since RPA maintains consistent documentation and audit trails and supports adherence to HIPAA, GDPR, and other regulatory frameworks.
• The convergence of RPA with artificial intelligence, machine learning, and natural language processing into intelligent automation and hyperautomation, extending bots to unstructured data and cognitive tasks.
• The growth of revenue cycle management automation, in which claims submission, denial prevention, and reimbursement optimization deliver measurable financial returns for providers.
• The shift toward cloud-based and low-code or no-code platforms, which lower the barrier to adoption and empower non-technical clinical and administrative staff to build automations.

Key Companies in RPA in Healthcare Market

The competitive landscape is led by the following active manufacturers:

• UiPath Inc.
• Automation Anywhere Inc.
• SS&C Blue Prism
• Pegasystems Inc.
• Microsoft Corporation
• International Business Machines Corporation
• NICE Ltd.
• WorkFusion Inc.
• Tungsten Automation (formerly Kofax)
• EdgeVerve Systems Limited (Infosys)

For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies relevant to the market assessment.

RPA in Healthcare Market Size

The following table summarizes the headline market metrics for the global RPA in healthcare market across the base year and the forecast horizon.

All market values are expressed in USD and represent DelveInsight estimates synthesized from primary and secondary research.

Factors Contributing to the Growth of the RPA in Healthcare Market

Market Drivers

Administrative Efficiency and Cost Reduction

The foundational driver of the RPA in healthcare market is the imperative to improve administrative efficiency and reduce operational cost, because healthcare is uniquely burdened with the high-volume, repetitive, rule-based administrative work that RPA is designed to eliminate. Hospitals and clinics are burdened with time-consuming administrative tasks such as data entry, claims processing, and billing, and RPA reduces manual workloads, cuts operational costs, and improves accuracy by having software bots perform these tasks continuously and without the errors that manual processing introduces. The financial pressure upon healthcare providers is intense and persistent, since margins are thin, administrative overhead is a large and growing share of total healthcare expenditure, and every error in billing or claims translates into delay, denial, or lost revenue, so an automation that reduces both cost and error addresses two of the most pressing problems facing every provider and payer simultaneously. The returns are measurable and often dramatic, with documented deployments reducing labor costs substantially and accelerating claims verification severalfold, and the scale of the addressable administrative workload means that even partial automation of a single process such as claims management or revenue cycle can justify the investment. Because administrative burden is universal across healthcare, because the financial pressure to reduce it is unrelenting, and because RPA delivers a rapid and quantifiable return, this driver provides the most durable foundation for market growth. 

Healthcare Labor Shortages and Workforce Burnout

Healthcare labor shortages and workforce burnout are a powerful and distinctive driver of the RPA in healthcare market, because automation directly addresses the gap between the work that must be done and the workforce available to do it. The World Health Organization projects a shortfall of some 11 million health workers by 2030, concentrated in but not limited to low- and middle-income countries, and the staffing shortages that intensified after the COVID-19 pandemic have left healthcare organizations struggling to staff both clinical and administrative functions. RPA responds to this directly by deploying digital assistants to handle the repetitive administrative processes that would otherwise consume the time of scarce human workers, allowing those workers to focus on patient care and on the complex tasks that require human judgment. The burnout dimension is as important as the raw shortage, since a substantial part of clinician and administrative staff dissatisfaction arises from the burden of repetitive documentation, data entry, and administrative work, and shifting that burden to bots improves both retention and the quality of the work that remains. Because the workforce shortage is structural, long-term, and worsening as populations age and demand rises, and because RPA offers an immediate means of extending the capacity of the existing workforce, labor shortage is a central and durable driver of adoption. 

Digitization of Healthcare and EHR Integration

The increasing digitization of healthcare services is a central driver of the RPA in healthcare market, because RPA both depends upon and accelerates the digital transformation of healthcare operations, and the widespread adoption of electronic health records has created the digital substrate upon which bots operate. Modern RPA solutions integrate with electronic health record platforms such as Epic and Cerner to auto-update patient records, manage scheduling, and synchronize data across systems, ensuring seamless digital operations, and this integration is what allows a bot to extract billing codes and demographics directly from the record, create and validate a claim, and post the resulting payment without manual intervention. The digitization of healthcare has produced a proliferation of digital systems that frequently do not communicate with one another, and RPA has emerged as a practical means of bridging them, since a bot can emulate the human user interacting with multiple systems through their interfaces even where no application programming interface or formal integration exists. This capability is particularly valuable in healthcare, where legacy systems and limited interoperability are pervasive, and where modern RPA enhanced with natural language processing and computer vision can automate workflows across systems that resist conventional integration. Because healthcare digitization is broad, continuing, and incomplete, and because RPA both extends and connects it, this driver provides sustained momentum for the market. 

Compliance, Audit Readiness, and Data Governance

The demand for compliance and audit readiness is an important driver of the RPA in healthcare market, because healthcare is among the most heavily regulated of all industries and because RPA provides a reliable and continuous means of maintaining the documentation and controls that regulation requires. Healthcare providers must adhere to strict regulations such as the Health Insurance Portability and Accountability Act in the United States and the General Data Protection Regulation in Europe, and manual compliance tracking is a tedious and error-prone process that RPA can significantly simplify by automating the creation of audit logs and access records, the compilation of compliance reports for internal review and external audit, and the real-time monitoring of data access and user activity for violations of security protocols. Because a bot performs these tasks consistently and continuously, it provides a round-the-clock compliance capability that human staff cannot match, detecting potential breaches or policy violations and issuing instant alerts for swift response. The consequences of non-compliance in healthcare are severe, encompassing substantial financial penalties, reputational harm, and the loss of patient trust, which makes the reliability and auditability that RPA provides genuinely valuable rather than merely convenient. Because the regulatory burden is heavy, permanent, and rising, and because RPA converts compliance from a manual and fallible process into an automated and auditable one, compliance is a meaningful and durable driver of adoption. 

Convergence with Artificial Intelligence and Hyperautomation

The convergence of RPA with artificial intelligence, machine learning, and natural language processing is a central and accelerating driver of the market, because it expands the range of processes that can be automated from the simple and structured to the complex and cognitive, dramatically enlarging the addressable market. Traditional RPA struggles with unstructured data such as clinical notes, physician dictations, and patient emails, but by integrating with artificial intelligence, and specifically with natural language processing, bots can now understand and process this information, extracting key data, summarizing documents, and responding to inquiries with human-like understanding. This intelligent automation moves bots beyond rule-based actions to more informed decisions, such as identifying potential fraud in claims processing or flagging inconsistencies in medical records, and artificial-intelligence-powered RPA can analyze large volumes of patient data to identify patterns and support proactive care. The broader trajectory is toward hyperautomation, the end-to-end automation of entire business processes, supported by process mining that identifies the most impactful processes to automate, and toward agentic systems that combine multiple automated steps into a seamless workflow spanning the patient journey. Because the fusion of RPA and artificial intelligence extends automation into the unstructured and cognitive work that constitutes the majority of healthcare processes, and because it is advancing rapidly, this convergence is among the most powerful drivers of long-term market growth. 

Growth of Revenue Cycle Management Automation

The rapid growth of revenue cycle management automation is a significant driver of the RPA in healthcare market, because the revenue cycle is the process in which automation delivers the most direct, measurable, and compelling financial return, and it has consequently become the leading application of RPA in healthcare. The revenue cycle spans patient intake and insurance verification, prior authorization, claim generation and submission, denial management, and payment posting and reconciliation, and each stage is repetitive, rule-based, and financially consequential, so automating it both reduces cost and directly improves cash flow. Documented deployments demonstrate the value, with automation reducing claim denials by identifying discrepancies before submission, improving cash flow and financial operations through predictive automation, automating a large share of cost estimates, and increasing point-of-service collections substantially. The financial pressure upon providers, combined with the direct and quantifiable return that revenue cycle automation delivers, has made it the entry point for RPA adoption in many organizations and the anchor of the largest application segment, and specialized revenue cycle automation platforms have emerged alongside the horizontal RPA vendors to serve it. Because the revenue cycle is universal, financially critical, and highly automatable, and because the return on its automation is immediate and measurable, its growth is a central contributor to the expansion of the market. 

Cloud-Based and Low-Code Platforms

The shift toward cloud-based and low-code or no-code platforms is an important driver of the RPA in healthcare market, because it lowers the barriers of cost, infrastructure, and technical skill that have historically limited adoption, and it thereby broadens the market to a far larger population of healthcare organizations and users. Traditional on-premise RPA requires substantial upfront investment in hardware infrastructure, ongoing maintenance, and dedicated information technology resources, barriers that are difficult for many resource-constrained facilities to overcome, whereas cloud-based RPA eliminates these through a flexible consumption-based model delivered over the internet, allowing organizations to scale their automation up or down without significant upfront investment and to integrate more easily with existing systems. Low-code and no-code platforms address the skills barrier in parallel, allowing healthcare professionals with little or no programming experience to build and deploy their own automation solutions, empowering the citizen developers, including clinicians and administrators, who understand their own departmental processes best and can automate the simple repetitive tasks within them. As the barrier to entry falls, adoption accelerates across healthcare institutions of every size, and the combination of cloud scalability and low-code accessibility extends RPA beyond the large systems that pioneered it to the mid-sized and smaller providers that constitute the majority of the market. Because these platform shifts expand the addressable market and accelerate adoption, they are a meaningful contributor to growth. 

Market Restraints

Despite a compelling efficiency case and rapid growth, the RPA in healthcare market faces several material constraints. The most significant is the concern regarding data security and privacy, since healthcare RPA bots handle sensitive protected health information, and the risks of breach, of non-compliance with data protection regulation, and of the ethical questions surrounding automation slow adoption in some areas, requiring that bots be configured with encryption, access controls, and secure integration, and that organizations satisfy themselves that automation does not expand the attack surface for sensitive data. A second and pervasive constraint is the difficulty of integration with legacy systems, since many hospitals still rely upon outdated information technology systems that lack application programming interfaces or interoperability, making the integration of RPA solutions more complex and costly. Although modern RPA can emulate the user interface where no formal integration exists, this approach introduces its own fragility. That fragility is itself a third constraint, since a bot interacts with underlying software through the user interface, and any change to that interface, such as a mandatory update to an electronic health record system, can break the programming of the bot immediately, requiring costly and time-consuming reconfiguration and creating a risk of operational downtime that necessitates robust governance, monitoring, and version control and adds an unavoidable overhead to the automation ecosystem. A fourth constraint is change management and workforce resistance, since the transition from manual to automated processes requires cultural change, staff training, and process redesign that can delay adoption in conservative healthcare environments, and since staff may perceive automation as a threat. Additional constraints include the high implementation and maintenance cost, which is a particular barrier for smaller providers and encompasses software licenses, development, customization, and integration, and the scarcity of the specialized skills required to design, deploy, and maintain automation at scale. Together, these security, integration, maintenance, organizational, and cost factors ensure that growth, while rapid, proceeds against genuine friction. Source: manufacturer disclosures; regulatory frameworks; peer-reviewed health informatics literature.

RPA in Healthcare Market Segment Analysis

The global RPA in healthcare market by type (software and services), by application (claims management, patient data management and electronic health record automation, revenue cycle management, billing and payment, appointment scheduling and registration, regulatory and compliance, and others), by end-user (healthcare providers, healthcare payers, pharmaceutical and life sciences companies, and others), and by geography (North America, Europe, Asia-Pacific, and the Rest of the World).

By Type

Dominant Subsegment: Software.

The software segment accounted for a 74% share of the RPA in healthcare market in 2025. Software dominates the type structure because the automation platform itself is the core of every RPA deployment and the element upon which the recurring license revenue that constitutes the majority of the market depends. Healthcare organizations increasingly rely upon licensed RPA software to automate high-volume, repetitive clinical and administrative workflows such as claims management, billing, and prior authorization, and the licensing model, in which a provider or payer pays for the software platform and the bots it runs, anchors the value of the market in the software layer. The integration of intelligent automation, in which software bots are enhanced with artificial intelligence and machine learning for cognitive tasks such as processing the unstructured data of clinical documentation, is solidifying the revenue contribution of the software segment by expanding the range and value of what the platform can automate. Services constitute the second type category and a rapidly growing one, encompassing the implementation, integration, support and maintenance, and training and consulting required to deploy and sustain automation, and this segment is the fastest growing component because the complexity of deploying RPA across legacy healthcare information technology systems, and of maintaining bots against the interface changes that break them, generates substantial and recurring demand for expert services. The two are complementary, since software creates the platform and services realize its value, but the software segment retains the leading share, reinforced by the shift toward artificial-intelligence-enhanced platforms. Software is expected to retain its leading share throughout the forecast period.

By Application

Dominant Subsegment: Claims Management.

The claims management segment accounted for a 33% share of the RPA in healthcare market in 2025. Claims management dominates the application structure because it is the highest-volume, most repetitive, and most financially consequential of the administrative processes that RPA automates, and because the return on automating it is immediate and measurable. Claims processing is a complex, multi-step workflow spanning data collection, claim creation, validation against payer-specific rules, submission, status tracking, and the handling of denials and resubmissions, and every stage is rule-based and error-prone, so automating it both reduces the cost of processing and reduces the denials and delays that erode provider revenue. The financial stakes are decisive, since a denied or delayed claim represents lost or deferred revenue, and RPA bots that validate claims before submission, catch the errors that would otherwise lead to denial, and automatically handle resubmission deliver a direct and quantifiable improvement in cash flow, which is why claims management and the broader revenue cycle constitute the leading entry point for RPA adoption. Patient data management and electronic health record automation form a substantial second application, automating the extraction, updating, transfer, and verification of clinical data across systems, and revenue cycle management, billing and payment, appointment scheduling and registration, and regulatory and compliance complete the application structure, each automating a distinct high-volume administrative process. The convergence of RPA with artificial intelligence is extending automation across all of these applications toward the unstructured and cognitive work they involve. Claims management is expected to retain its leading share throughout the forecast period.

By End-User

Dominant Subsegment: Healthcare Providers.

The healthcare providers segment accounted for a 55% share of the RPA in healthcare market in 2025. Healthcare providers dominate the end-user structure because hospitals, health systems, and clinics operate the largest and most diverse population of the administrative and clinical workflows that RPA automates, and because the financial and workforce pressures that drive adoption bear most heavily upon them. Providers perform the patient scheduling and registration, the electronic health record management and coding, the billing and revenue cycle management, and the compliance documentation that constitute the core applications of healthcare RPA, and the sheer volume and repetitiveness of this work, combined with the thin margins and staffing shortages under which providers operate, make automation both attractive and financially necessary. The provider segment also spans the widest range of RPA applications, from the front-office patient-facing processes through the mid-office clinical documentation to the back-office financial and compliance functions, which broadens its demand across the full scope of the market. Healthcare payers constitute the second end-user category and a substantial one, automating the claims processing, member enrollment, eligibility verification and authorization, fraud detection, and customer service that define the insurance function, where the volume of transactions is enormous and highly automatable. Pharmaceutical and life sciences companies form a third category, automating regulatory compliance and reporting, pharmacovigilance and adverse event reporting, clinical trial management, and supply chain workflows, and other end-users complete the structure. Healthcare providers are expected to retain their leading share throughout the forecast period.

RPA in Healthcare Market Region Analysis

Dominant Region: North America

North America accounted for a 40% share of the global RPA in healthcare market in 2025. The region led the market due to the high adoption of digital health infrastructure, a mature regulatory environment, and the presence of major RPA vendors including UiPath, Automation Anywhere, and Blue Prism. Healthcare providers in the United States and Canada are leveraging RPA to streamline billing, claims processing, and patient registration, and the region combines the largest and most digitized healthcare system in the world, in which electronic health record adoption is near universal, with the most intense administrative cost pressure and the deepest concentration of automation vendors and expertise. The complexity and cost of the United States healthcare reimbursement system, with its multiplicity of payers, its prior authorization requirements, and its high administrative overhead, creates an unusually strong incentive for revenue cycle and claims automation, and the documented deployments that demonstrate the value of RPA, from health system revenue cycle transformations to the automation of financial estimation and collections, are concentrated in the region. A mature regulatory environment, including the Health Insurance Portability and Accountability Act framework within which compliant automation operates, supports adoption, and the presence of the leading platform vendors ensures continuous innovation and implementation capacity. The region is expected to retain its leading position throughout the forecast period.

Fastest Growing Region: Asia-Pacific

Asia-Pacific is projected to register the fastest compound annual growth rate in the RPA in healthcare market through 2034. The region is emerging as a high-growth market, and the rapid digitization of hospitals, rising investment in artificial intelligence and automation, and government initiatives to modernize healthcare systems are fueling demand across the Asia-Pacific. The region combines very large and rapidly growing healthcare systems with an accelerating shift toward digital health infrastructure, and as hospitals across China, India, Japan, and South Korea digitize their records and operations, they create the digital substrate upon which RPA operates and the administrative workload that it automates. Government initiatives to modernize healthcare, expand coverage, and improve efficiency are channeling investment into health information technology and automation, and the combination of large populations, rising healthcare demand, and persistent workforce constraints makes the efficiency and capacity gains of RPA especially valuable. The rising investment in artificial intelligence and automation across the region positions it to adopt the intelligent-automation and cloud-based approaches that represent the frontier of the market, and both international vendors and capable regional providers are expanding to serve the opportunity. Because the region combines rapid digitization, large and growing healthcare systems, supportive government investment, and a low current base of automation, it is expected to grow faster than the mature markets over the forecast period. Regional growth is expected to exceed the global average across every segment.

Regional Commentary

North America

North America leads on value and adoption, holding a 40% share in 2025. The region leads through high adoption of digital health infrastructure, a mature regulatory environment, and the presence of the major RPA vendors including UiPath, Automation Anywhere, and Blue Prism. The complexity and administrative cost of the United States reimbursement system create an unusually strong incentive for claims and revenue cycle automation, and the documented health system deployments that demonstrate the value of RPA are concentrated in the region. Near-term dynamics are shaped by the convergence of RPA with artificial intelligence, the growth of revenue cycle automation, cloud and low-code adoption, and the intense administrative cost pressure upon providers and payers.

Europe

Europe is a substantial and high-growth market, and the emphasis upon reducing healthcare costs, an aging population, and strong data privacy regulation such as the General Data Protection Regulation are encouraging providers to implement secure RPA solutions. The region combines large, mostly public healthcare systems under sustained cost pressure with advanced digitization in several countries, and documented deployments in the United Kingdom National Health Service, automating patient registration, scheduling, and referral management, illustrate the value of RPA in a public health system context. The stringent European data protection framework shapes adoption toward secure and compliant automation and favors vendors able to demonstrate rigorous governance, while public procurement and budget constraints influence the pace and scale of deployment across Germany, the United Kingdom, France, and the other principal markets.

Asia-Pacific

Asia-Pacific is the fastest-growing region, and the rapid digitization of hospitals, rising investment in artificial intelligence and automation, and government initiatives to modernize healthcare systems are fueling demand. The region combines very large and rapidly growing healthcare systems across China, India, Japan, and South Korea with an accelerating shift toward digital health infrastructure, and government modernization initiatives are channeling investment into health information technology and automation. Large populations, rising healthcare demand, and persistent workforce constraints make the efficiency and capacity gains of RPA especially valuable, and both international and regional vendors are expanding to serve the opportunity. Growth exceeds the global average across every segment.

Rest of World

The Rest of the World comprises the Middle East, Africa, and South America. Adoption is stratified. The Gulf states are investing heavily in digital health infrastructure and hospital modernization as part of broader economic diversification, and the larger Latin American markets, particularly Brazil, support growing private healthcare systems that are adopting automation, together representing steady growth. Much of Africa has limited digital health infrastructure and constrained information technology budgets, so RPA adoption is concentrated in the larger private systems and the more digitized markets. Regional growth will be driven by investment in digital health infrastructure, the modernization of hospital operations, the rising administrative burden of expanding healthcare systems, and the availability of cloud-based automation that lowers the barrier to adoption.

RPA in Healthcare Market Competitive Landscape

The global RPA in healthcare market is classified as Moderately Concentrated. The market is led by the major horizontal enterprise automation platforms, whose healthcare offerings hold a substantial combined share, complemented by intelligent-automation and document-processing specialists and by a growing tier of healthcare-specific automation and revenue cycle vendors. Competition centers upon the breadth and intelligence of the automation platform, the depth of pre-built healthcare templates and integrations, the strength of electronic health record and health IT integration, security and regulatory compliance, and increasingly upon the convergence of RPA with artificial intelligence into intelligent automation. The competitive landscape is evaluated across the following dimensions:

• Market concentration: Moderately concentrated, with the major horizontal automation platforms holding a substantial combined share alongside intelligent-automation specialists and a growing tier of healthcare-specific vendors, and with the scale, platform breadth, and integration depth of the leaders constituting a barrier to entry.
• Leading players: UiPath, Automation Anywhere, SS&C Blue Prism, and Pegasystems lead the healthcare RPA market through broad and increasingly AI-enabled automation platforms, with Microsoft and IBM competing through enterprise automation and artificial intelligence portfolios, and NICE, WorkFusion, Tungsten Automation, and EdgeVerve contesting intelligent-automation, document-processing, and services-led segments.
• Geographic reach: The leading platform vendors maintain global commercial, partner, and implementation networks, which matter because healthcare RPA requires local integration, compliance, and support, while healthcare-specific and revenue cycle vendors concentrate upon the markets, notably the United States, where the administrative complexity that they address is greatest.
• Product portfolio strength: Competitive advantage rests upon the breadth and intelligence of the platform, the depth of pre-built healthcare bots and templates for claims, billing, scheduling, and prior authorization, and the strength of integration with electronic health record and health IT systems, since healthcare buyers value a platform that addresses their specific workflows out of the box and integrates with their existing systems.
• Pipeline strength: Development is concentrated in the fusion of RPA with artificial intelligence, machine learning, and natural language processing for cognitive and unstructured-data automation, in agentic and hyperautomation platforms, in process mining, in cloud-based and low-code delivery, and in healthcare-specific intelligent automation.
• Strategic partnerships: Collaboration spans partnerships between platform vendors and health systems, payers, and revenue cycle organizations to deploy automation at scale, exemplified by multi-year automation programs transforming revenue cycle operations, alongside alliances with electronic health record vendors, system integrators, and cloud providers.
• M&A activity: Consolidation has reshaped the field, exemplified by the acquisition of Blue Prism by SS&C and the rebranding of Kofax as Tungsten Automation, and major software and services companies continue to acquire intelligent-automation, document-processing, and healthcare-specific capabilities to complete their platforms.
• Innovation focus: Innovation is shifting toward agentic and generative artificial intelligence integrated with RPA, the automation of unstructured clinical data, end-to-end hyperautomation across the patient journey, process mining, cloud-native and low-code delivery, and healthcare-specific intelligent automation for revenue cycle and clinical workflows.
• Regulatory standing: The ability to operate in compliance with healthcare data protection frameworks including the Health Insurance Portability and Accountability Act and the General Data Protection Regulation, with the security, audit trails, and access controls they require, is a decisive competitive credential, and the handling of protected health information makes demonstrated security and compliance a prerequisite for adoption.

RPA in Healthcare Market Recent Developmental Activities

In early 2025, Omega Healthcare expanded its partnership with UiPath to automate over 100 million annual transactions in revenue cycle management, achieving a 50% reduction in processing time and 99.5% data accuracy. Strategic significance: an automation program operating at the scale of over 100 million annual transactions demonstrated the enterprise-grade capability of healthcare RPA in the revenue cycle, the largest application, and it validated the measurable financial and accuracy returns that anchor adoption.

In March 2025, Coronis Health partnered with UiPath to enhance its revenue cycle management operations using RPA, process mining, and artificial-intelligence-driven decision support, streamlining claim submission, denial detection, and reimbursement optimization. Strategic significance: the combination of RPA with process mining and artificial intelligence exemplified the convergence toward intelligent automation and hyperautomation, and the reduction of claim denials by identifying discrepancies before submission illustrated the direct cash-flow benefit that drives revenue cycle automation.

In March 2025, Waystar and Baylor Scott & White Health implemented artificial-intelligence-powered RPA for patient financial estimation, automating some 70% of cost estimates and increasing point-of-service collections substantially. Strategic significance: the automation of patient financial estimation extended RPA into the patient-facing financial experience, addressing both provider collections and price transparency, and it illustrated the role of specialized healthcare automation platforms alongside the horizontal RPA vendors.

In October 2024, UiPath announced that it had transformed operations for Omega Healthcare through artificial-intelligence-powered automation, recognizing Omega Healthcare as a UiPath AI25 Award Winner at UiPath FORWARD for its use of automation to drive strategic change. Strategic significance: the recognition underscored the maturation of healthcare RPA from task automation toward artificial-intelligence-driven transformation, and it positioned the leading platform vendor and a major healthcare services provider as reference exemplars of the intelligent-automation model.

In 2024 and 2025, several United Kingdom National Health Service trusts adopted SS&C Blue Prism bots to manage patient registration and backlog scheduling, reducing administrative delays and eliminating over 100,000 hours of paperwork annually. Strategic significance: the deployment demonstrated the value of RPA in a large public health system under acute capacity and backlog pressure, extending the proven use cases beyond the United States reimbursement context into publicly funded care.

In March 2024, East Lancashire NHS Trust automated appointment scheduling for some 15,000 patient referrals per month using RPA bots that handled referrals, checked physician availability, booked appointments in the electronic health record, and sent confirmations, saving some 83,600 sheets of paper monthly and reducing workload equivalent to 2.5 full-time staff. Strategic significance: a documented, quantified deployment in patient scheduling and registration illustrated the front-office efficiency and workforce-capacity benefits of RPA and the tangible administrative savings it delivers in a public health system.

In 2024 and 2025, UiPath advanced its platform toward agentic automation, combining RPA with artificial-intelligence agents and generative artificial intelligence to automate more complex and cognitive healthcare workflows. Strategic significance: the move toward agentic automation reflected the industry-defining convergence of RPA and artificial intelligence, extending automation from structured rule-based tasks into the unstructured and decision-oriented work that constitutes the majority of healthcare processes.

In 2024 and 2025, Automation Anywhere expanded its cloud-native, artificial-intelligence-integrated automation platform with pre-built healthcare bots for claims, billing, inventory, and patient scheduling. Strategic significance: the deepening of pre-built healthcare-specific automation lowered the barrier to deployment for providers and payers and reinforced competition on the depth of healthcare templates and integrations rather than upon the automation engine alone.

In 2023 and 2024, SS&C Technologies integrated Blue Prism following its acquisition, forming SS&C Blue Prism and combining enterprise-grade RPA with broader financial and healthcare process capabilities. Strategic significance: the consolidation illustrated the acquisition-led assembly of automation portfolios and strengthened the position of a secure, governance-focused platform well suited to the compliance requirements of large healthcare systems.

In 2023 and 2024, Kofax rebranded as Tungsten Automation, sharpening its focus upon intelligent document processing and process orchestration for document-heavy healthcare workflows. Strategic significance: the repositioning reflected the strategic importance of intelligent document processing in healthcare, where much of the highest-value work involves the unstructured documents that traditional RPA cannot process without artificial-intelligence enhancement.

In 2024 and 2025, Microsoft and Pegasystems advanced their healthcare automation through the integration of generative artificial intelligence and business process management with RPA, extending end-to-end automation across clinical and administrative workflows. Strategic significance: the entry and expansion of the large enterprise software vendors intensified competition and accelerated the convergence of RPA with artificial intelligence and process management toward the hyperautomation of the full patient journey.

In 2024 and 2025, emerging revenue cycle and interoperability startups, including healthcare-specific automation and speech-to-text clinical workflow vendors, advanced focused automation capabilities from revenue cycle management to interoperable electronic health record platforms. Strategic significance: the emergence of focused healthcare automation startups illustrated the vitality of the market beyond the horizontal platforms and the opportunity in the healthcare-specific workflows, particularly revenue cycle and interoperability, where domain depth creates defensible differentiation.

RPA in Healthcare Market Segmentation

RPA in Healthcare Market Assessment by Type

• Software
• Services

RPA in Healthcare Market Assessment by Application

• Claims Management
• Patient Data Management and EHR Automation
• Revenue Cycle Management
• Billing and Payment
• Appointment Scheduling and Registration
• Regulatory and Compliance
• Others

RPA in Healthcare Market Assessment by End-User

• Healthcare Providers
• Healthcare Payers
• Pharmaceutical and Life Sciences Companies
• Others

RPA in Healthcare Market Assessment by Geography

• North America

• United States RPA in Healthcare Market Size in USD million (2023-2034)
• Canada RPA in Healthcare Market Size in USD million (2023-2034)
• Mexico RPA in Healthcare Market Size in USD million (2023-2034)
• Europe
• France RPA in Healthcare Market Size in USD million (2023-2034)
• Germany RPA in Healthcare Market Size in USD million (2023-2034)
• United Kingdom RPA in Healthcare Market Size in USD million (2023-2034)
• Italy RPA in Healthcare Market Size in USD million (2023-2034)
• Spain RPA in Healthcare Market Size in USD million (2023-2034)
• Rest of Europe RPA in Healthcare Market Size in USD million (2023-2034)
• Asia-Pacific
• China RPA in Healthcare Market Size in USD million (2023-2034)
• Japan RPA in Healthcare Market Size in USD million (2023-2034)
• India RPA in Healthcare Market Size in USD million (2023-2034)
• Australia RPA in Healthcare Market Size in USD million (2023-2034)
• South Korea RPA in Healthcare Market Size in USD million (2023-2034)
• Rest of Asia-Pacific RPA in Healthcare Market Size in USD million (2023-2034)
• Rest of the World
• Middle East RPA in Healthcare Market Size in USD million (2023-2034)
• Africa RPA in Healthcare Market Size in USD million (2023-2034)
• South America RPA in Healthcare Market Size in USD million (2023-2034)

RPA in Healthcare Market Recent Industry Trends and Milestones (2023-2026)

RPA in Healthcare Market Startup Funding and Investment Trends

Investment in the RPA in healthcare field concentrates upon the healthcare-specific application of automation and upon the convergence of RPA with artificial intelligence, principally revenue cycle automation, interoperability and electronic health record automation, and the intelligent automation of unstructured clinical workflows. Because the horizontal platform vendors hold broad and increasingly artificial-intelligence-enabled platforms that a new entrant cannot readily match, innovators typically enter through domain depth in the highest-value healthcare workflows, particularly revenue cycle and interoperability, where healthcare-specific knowledge creates defensible differentiation. The table below summarizes representative companies advancing the next generation of healthcare automation technology.

Capital formation in this field is shaped by the strength of the horizontal automation platforms and by the depth of domain knowledge that the highest-value healthcare workflows require, which together mean that a new entrant competes most effectively through healthcare-specific capability rather than through a general automation engine. Revenue cycle automation is the dominant investment thesis, since the revenue cycle is the largest, most financially consequential, and most automatable healthcare workflow, and it has attracted substantial capital for platforms that apply artificial intelligence and agentic automation to claims, denials, and reimbursement. Interoperability and electronic health record automation constitute a second thesis, addressing the fragmentation and limited application programming interface access that pervade healthcare information technology, and the intelligent automation of unstructured clinical workflows, including documentation and speech-to-text, a third. The convergence of RPA with generative and agentic artificial intelligence has drawn particular investor interest, since it extends automation into the cognitive work that constitutes the majority of healthcare processes. The archetypal outcome for an innovator is growth into a healthcare-specific automation platform, partnership with a horizontal vendor or health system, or acquisition. The principal risks are the strength of the incumbent platforms, the security and compliance burden of handling protected health information, the fragility of automation against changing systems, and the long sales and integration cycles of healthcare.